H. Ohashi et al., CHARACTERIZATION OF TYPE-I IGF RECEPTOR AND IGF-I MESSENGER-RNA EXPRESSION IN CULTURED HUMAN AND BOVINE GLOMERULAR CELLS, Regulatory peptides, 48(1-2), 1993, pp. 9-20
Glomerular hypertrophy is reported in several endocrine disorders such
as acromegaly and diabetes mellitus, where abnormalities of growth ho
rmone and insulin-like growth factor (IGF-I) have been reported. In th
e present report, we have cultured bovine and human glomerular endothe
lial cells, and bovine glomerular epithelial and mesangial cells, and
characterized the expression of IGF-I mRNA and its receptor in these c
ells. High affinity, specific receptors for IGF-I were identified in a
ll three types of cells by radioreceptor assays. Receptor number (R(o)
) derived by Scatchard analysis revealed an unusually high number of T
ype I IGF receptors, approx. 1.2-105 receptors/cell in glomerular endo
thelial cells. Affinity crosslinking studies and immunoprecipitation w
ith antibodies against the Type I IGF receptor identified the alpha-su
bunit of the IGF-I receptor as having a molecular mass of 140 kDa. Bio
logically, IGF-I was more potent than insulin or IGF-II in stimulating
DNA synthesis in glomerular endothelial cells. Northern blot analysis
showed that glomerular and aortic endothelial cells expressed IGF-I m
RNA of 1.7 kb. In contrast, renal glomeruli showed several IGF-I mRNAs
of 7.5, 1.7 and 1.2 kb. Thus, the demonstration of both a prepondence
of Type I IGF receptors coupled with the growth promoting effects of
IGF-I in glomerular endothelial and epithelial cells, as well as the l
ocal production of IGF-I mRNA suggests that IGF-I serves an important
role as an autocrine or paracrine regulator of the growth of renal glo
meruli.